Inovio Pharmaceuticals, Inc. (INO)
2.175
+0.08
(+4.07%)
USD |
NASDAQ |
Dec 09, 16:00
2.175
0.00 (0.00%)
After-Hours: 17:15
Inovio Pharmaceuticals EPS Diluted (Quarterly): -0.8721 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Agenus, Inc. | 1.944 |
| Perspective Therapeutics, Inc. | -0.3495 |
| Arcturus Therapeutics Holdings, Inc. | -0.4946 |
| Capricor Therapeutics, Inc. | -0.5375 |
| Myomo, Inc. | -0.0869 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -45.50M |
| Total Expenses (Quarterly) | 45.50M |
| Enterprise Value | 102.81M |
| Earnings Yield | -118.8% |
| Normalized Earnings Yield | -110.41 |